Clinician-trialist rounds: 17. Mind your explanatory and pragmatic attitudes! Part 2: How?

Abstract

Get full access to this article

View all access options for this article.

References

Thorpe

Zwarenstein

Oxman

. A Pragmatic-Explanatory Continuum Indicator Summary (PRECIS): A tool to help trial designers. J Clin Epidemiol 2009; 62: 464–75 (also in CMAJ 2009; 180: E47–57).

Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 116–22.

Sackett

. Clinician-trialist rounds: 16. Mind your explanatory and pragmatic attitudes! Part 1: What? Clin Trials, in press.

Kaczorowski

Chambers

Dolovich

. Improving cardiovascular health at population level: 39 community cluster randomized trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011; 342: d442.

Tosh

Soares-Weiser

Adams

. Pragmatic vs. explanatory trials: The Pragmascope tool to help measure differences in protocols of mental health randomized controlled trials. Dialogues Clin Neurosci 2011; 13: 209–15.

Koppenaal

Linmans

Knottnerus

Spigt

. Pragmatic vs. explanatory: An adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice. J Clin Epidemiol 2011; 64: 1095–101.

Bratton

Nunn

. Alternative approaches to tuberculosis treatment evaluation: The role of pragmatic trials. Int J Tuberc Lung Dis 2011; 15: 440–46.

Selby

Brosky

Raymond

Ranger

. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial. BMC Med Res Methodol 2012; 12: 101.

Bratton

Nunn

Wojnarowska

. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: The bullous pemphigoid steroids and tetracyclines study. Trials 2012; 13: 50.

10.

Riddle

Johnson

Jensen

. The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: Experiences from an investigative team. J Clin Epidemiol 2010; 63: 1271–75.

11.

Kent

Kitsios

. Commentary. Against pragmatism: On efficacy, effectiveness and the real world. Trials 2009; 10: 48.